Statistics from Altmetric.com
Lowering the bleeding risk in intra-arterial thrombolysis without losing efficiency by excluding adjunctive heparin
Symptomatic intracerebral haemorrhage (sICH) is the main complication of intravenous (IVT) and intra-arterial thrombolysis (IAT). Factors of grave bleedings after thrombolysis have been recently reviewed.1 Immediate adjunctive heparin is classic in IAT. High doses of heparin may be suspected as a factor of bleeding in IAT on the basis of the Pro-Urokinase (r-proUK) for Acute Cerebral Thromboembolism (PROACT) I study, in which a higher sICH rate (27.3%) was observed in the high-heparin-dose subgroup, when compared with the low-heparin subgroup (6.7%). Even with the lower heparin regimen, the PROACT II study resulted in a sICH rate of …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.